John C. Thomas's most recent trade in Dogwood Therapeutics Inc. was a trade of 4,167 Stock Option (right to buy) done . Disclosure was reported to the exchange on Feb. 26, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Dogwood Therapeutics Inc. | Thomas John C. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2024 | 4,167 | 4,167 | - | - | Stock Option (right to buy) | |
Dogwood Therapeutics Inc. | John C. Thomas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 5,250 | 5,250 | - | - | Stock Option (right to buy) | |
Dogwood Therapeutics Inc. | John C. Thomas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2022 | 5,250 | 5,250 | - | - | Stock Option (right to buy) | |
Dogwood Therapeutics Inc. | John C. Thomas | Director | Purchase of securities on an exchange or from another person at price $ 5.65 per share. | 04 Jan 2022 | 1,000 | 1,000 | - | 5.7 | 5,650 | Common Stock |
ImmunityBio Inc | John C. Thomas | Former Director | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2021 | 5,000 | 202,477 | - | 0 | Common Stock | |
Dogwood Therapeutics Inc. | John C. Thomas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2021 | 7,875 | 7,875 | - | - | Stock Option (right to buy) |